Abstract
Acute renal failure (ARF)_is frequently encountered in the hospitalized setting. In this article, we discuss the etiology, pathogenesis, preventative therapies, and renal replacement strategies in patients with acute tubular necrosis, the most common form of hospitalized ARF.
Similar content being viewed by others
References
Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334(22):1448–1460.
de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2002;26(7):915–921.
Poole B, Schrier RW. Acute Renal Failure. In: Textbook of Critical Care (5th ed.) Fink M, Abraham E, Vincent J, Kochanek P, eds.). Elsevier Saunders, Philadelphia, 2005, 1039–1150.
Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hispitalacquired renal insufficiency: a prospective study. Am J Med 1983;74(2):243–248.
Kaufman J, Dhakal M, Patel B, Hamburger R. Community-acquired acute renal failure. Am J Kidney Dis 1991;17(2):191–198.
Blantz RC. Pathophysiology of pre-renal azotemia. Kidney Int 1998;53(2):512–523.
Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002;137(9):744–752.
Kobrin SM. Acute poststreptococcal glomerulonephritis and other bacterial infection-related glomerulonephritis. In: Diseases of the Kidney and Urinary Tract (7th ed.) (Schrier RW ed.). Lippincott, Williams & Wilkins, Philadelphia, 2001, 1617–1632.
Behrend T, Miller SB. Acute renal failure in the cardiac care unit: etiologies, outcomes, and prognostic factors. Kidney Int 1999;56(1):238–243.
Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993;306(6876):481–483.
Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int Suppl 1998;66:S16-S24.
Shapiro SR, Bennett AH. Recovery of renal function after prolonged unilateral ureteral obstruction. J Urol 1976;115(2):136–140.
Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114(1):5–14.
Kribben A, Wieder ED, Wetzels JF, et al. Evidence for role of cytosolic free calcium in hypoxia-induced proximal tubule injury. J Clin Invest 1994;93(5):1922–1929.
Edelstein CL, Wieder ED, Yaqoob MM, et al. The role of cysteine proteases in hypoxia-induced rat renal proximal tubular injury. Proc Natl Acad Sci USA 1995;92(17):7662–7666.
Schnermann J, Homer W, Smith Award lecture. The juxtaglomerular apparatus: from anatomical peculiarity to physiological relevance. J Am Soc Nephrol 2003;14(6):1681–1694.
Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002;62(6):2223–2229.
Levy EM, Viscoli CM, Horwitz RL. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275(19):1489–1494.
Bonomini V, Stefoni S, Vangelista A. Long-term patient and renal prognosis in acute renal failure. Nephron 1984;36(3):169–172.
Kjellstrand CM, Ebben J, Davin T. Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs 1981;27:45–50.
Druml W, Lax F, Grimm G, Schneeweiss B, Lenz K, Laggner AN. Acute renal failure in the elderly 1975–1990. Clin Nephrol 1994;41(6):342–349.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8(4):R204-R212.
Herget-Rosenthal S, Marggraf G, Husing J, et al. Eary detection of acute renal failure by serum cystatin C. Kidney Int 2004;66(3):1115–1122.
Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiogrphy. N Engl J Med 2003;348(6):491–499.
Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2000;93(1):C29-C34.
Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162(3):329–336.
Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291(19):2328–2334.
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343(3):180–184.
MA IW, Hladunewich M. Does the prophylactic use of N-acetyl-cysteine prevent contrast nephropathy in patients with renal insufficiency? Can Med Assoc J 2004;170(8):1231.
Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004;117(12):938–947.
Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis. Clin Cardiol 2004;27(11):607–610.
Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2004;2(1):38.
Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004;15(3):761–769.
Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak AJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004;43(1):1–9.
Isenbarger DW, Kent SM, O'Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003;92(12):1454–1458.
Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362(9384):598–603.
Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003;290(17):2284–2291.
Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003;349(14):1333–1340.
Gambaro G, Bertaglia G, Puma G, D'Angelo A. Diuretics and dopamine for the prevention and treatment of acute renal failure: a critical reappraisal. J Nephrol 2002;15(3):213–219.
Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000;356(9248):2139–2143.
Kellum JA, M Decker J. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29(8):1526–1531.
Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003;123(4):1266–1275.
Anderson RJ, Linas SL, Burns AS, et al. Nonoliguric acute renal failure. N Engl J Med 1977;296(20):1134–1138.
Gubern JM, Sancho JJ, Simo J, Sitges-Serra A. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice. Surgery 1988;103(1):39–44.
Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Neprhol Dial Transplant 1997;12(12):2592–2596.
Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD study group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002;288(20):2547–2553.
Cantarovich F, Rangoonwalla B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, doubleblind, placebo-controlled, multicenter trial. Am J Kidney Dis 2004;44(3):402–409.
Schneeweiss B, Graninger W, Stockenhuber F, et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990;52(4):596–601.
Druml W. Nutritional management of acute renal failure. J Ren Nutr 2005;15(1):63–70.
Chima CS, Meyer L, Hummell AC, et al. Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol 1993;3(8):1516–1521.
Gillum DM, Dixon BS, Yanover MJ, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986;25(5):249–255.
Mehta R, Mcdonald B, Gabbai F, et al. Continuous versus intermitent dialysis for acute renal failure (ARF) in the ICU: results from a randomized multicenter trial (Abstract). J Am Soc Nephrol 1996;7:A1044.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The authors do discuss the use of generic medications.
About this article
Cite this article
Mitra, A., Zolty, E., Wang, W. et al. Clinical acute renal failure diagnosis and management . Compr Ther 31, 262–269 (2005). https://doi.org/10.1385/COMP:31:4:262
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/COMP:31:4:262